Trial intelligence / Profile preview

Comparison of two anesthetic regimens for electroconvulsive therapy

2010-022739-13Phase 4Active

Sponsor
Hospital de la Santa Creu i Sant Pau Research Institute
Start
Oct 2010
Modality
Classical Binding Small Molecules → Small Molecules, Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 4 trial of rocuronium, Sugammadex, succinylcholine and atropine in mental disorder (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Hemodynamic impact of electroconvulsive therapy. Started Oct 2010; status: active.

02

Drugs

rocuroniumSugammadexsuccinylcholineatropine
03

Conditions

mental disorder

Beyond the preview

Go deeper on 2010-022739-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-022739-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call